TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 7 | 3 | 20 | 0 | 0 | 0 | 10 |
| P | %wins | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/23/18 09:32 | 7/23/18 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Pascale Adam | NJ | O | CFO | P | 10 | 0.3100 | 0 | 32 | 118 | 60 | D | ||||||||||||||
5/2/17 14:09 | 5/2/17 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Pascale Adam | NJ | O | CFO | P | 10 | 0.6300 | 0 | 16 | 138 | 27 | D | -80 | -63 | -38 | -5 | 15 | 19 | 11 | -9 | 6 | 2 | ||||
2/21/17 12:33 | 2/16/17 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Pascale Adam | NJ | O | CFO | P | 3 | 0.4600 | 0 | 7 | 154 | 12 | D | -85 | -74 | -71 | -48 | -39 | -30 | 2 | -12 | 7 | 4 | 20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |